Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Achieve Life Sciences Inc (NASDAQ: ACHV) closed at $3.26 in the last session, down -1.51% from day before closing price of $3.31. In other words, the price has decreased by -$1.51 from its previous closing price. On the day, 0.56 million shares were traded. ACHV stock price reached its highest trading level at $3.32 during the session, while it also had its lowest trading level at $2.96.
Ratios:
We take a closer look at ACHV’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.51 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 0.97 whereas as Long-Term Debt/Eq ratio is at 0.85.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On September 27, 2024, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $20.
Maxim Group reiterated its Buy rating for the stock on May 10, 2023, while the target price for the stock was revised from $8 to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Oki Mark K bought 10,000 shares for $2.89 per share. The transaction valued at 28,887 led to the insider holds 10,000 shares of the business.
Stewart Richard Alistair bought 10,000 shares of ACHV for $28,598 on Mar 17 ’25. The Chieve Executive Officer now owns 60,876 shares after completing the transaction at $2.86 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHV now has a Market Capitalization of 113073424 and an Enterprise Value of 99788336.
Stock Price History:
The Beta on a monthly basis for ACHV is 1.61, which has changed by -0.36699027 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, ACHV has reached a high of $5.59, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is 28.04%, while the 200-Day Moving Average is calculated to be -12.35%.
Shares Statistics:
According to the various share statistics, ACHV traded on average about 191.90K shares per day over the past 3-months and 267330 shares per day over the past 10 days. A total of 34.69M shares are outstanding, with a floating share count of 29.37M. Insiders hold about 15.32% of the company’s shares, while institutions hold 45.31% stake in the company. Shares short for ACHV as of 1745971200 were 2526989 with a Short Ratio of 13.17, compared to 1743379200 on 2870159. Therefore, it implies a Short% of Shares Outstanding of 2526989 and a Short% of Float of 9.34.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
As of right now, 4.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.28 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.22 and -$1.46 for the fiscal current year, implying an average EPS of -$1.35. EPS for the following year is -$0.77, with 6.0 analysts recommending between $1.31 and -$1.72.
